300 related articles for article (PubMed ID: 32558640)
1. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
2. Leveraging the advances in HIV for COVID-19.
McMahon JH; Hoy JF; Kamarulzaman A; Bekker LG; Beyrer C; Lewin SR
Lancet; 2020 Oct; 396(10256):943-944. PubMed ID: 33010825
[No Abstract] [Full Text] [Related]
3. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
4. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
5. Responding to Covid-19 - A Once-in-a-Century Pandemic?
Gates B
N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
[No Abstract] [Full Text] [Related]
6. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.
Al-Tawfiq JA; Memish ZA
Int J Antimicrob Agents; 2020 May; 55(5):105968. PubMed ID: 32259576
[TBL] [Abstract][Full Text] [Related]
7. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.
Liu X; Wang XJ
J Genet Genomics; 2020 Feb; 47(2):119-121. PubMed ID: 32173287
[No Abstract] [Full Text] [Related]
8. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
9. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
Calligari P; Bobone S; Ricci G; Bocedi A
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
11. World War against COVID-19: How strong is our armamentarium?
Ramachandran V; Marimuthu RR; Chinnambedu RS
Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
[TBL] [Abstract][Full Text] [Related]
12. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
13. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
[No Abstract] [Full Text] [Related]
14. COVID-19: The Need for Immunoprevention at Industrial Scale.
Halstead SB
Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
[No Abstract] [Full Text] [Related]
15. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
16. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
Chang R; Ng TB; Sun WZ
Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
[TBL] [Abstract][Full Text] [Related]
17. Lithium for the 2019 novel coronavirus.
Gómez-Bernal G
Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
[No Abstract] [Full Text] [Related]
18. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
Molecules; 2020 May; 25(11):. PubMed ID: 32485894
[TBL] [Abstract][Full Text] [Related]
19. Current and future therapeutical approaches for COVID-19.
Duan Y; Yao Y; Kumar SA; Zhu HL; Chang J
Drug Discov Today; 2020 Aug; 25(8):1545-1552. PubMed ID: 32574697
[TBL] [Abstract][Full Text] [Related]
20. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
Polansky H; Lori G
J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
